InChI=1S/C25H37NO4/c1- 2- 26- 25(30) 13- 9- 4- 3- 8- 12- 21- 22(24(29) 18- 23(21) 28) 17- 16- 20(27) 15- 14- 19- 10- 6- 5- 7- 11- 19/h3,5- 8,10- 11,16- 17,20- 24,27- 29H,2,4,9,12- 15,18H2,1H3,(H,26,30) /b8- 3- ,17- 16+/t20- ,21+,22+,23- ,24+/m0/s1 |
AQOKCDNYWBIDND-FTOWTWDKSA-N |
CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCc1ccccc1 |
|
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
antiglaucoma drug
Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye.
|
|
View more via ChEBI Ontology
(5Z)- 7- {(1R,2R,3R,5S)- 3,5- dihydroxy- 2- [(1E,3S)- 3- hydroxy- 5- phenylpent- 1- en- 1- yl]cyclopentyl}- N- ethylhept- 5- enamide
|
bimatoprost
|
ChemIDplus
|
bimatoprostum
|
WHO MedNet
|
(Z)- 7- ((1R,2R,3R,5S)- 3,5- Dihydroxy- 2- ((1E,3S)- 3- hydroxy- 5- phenyl- 1- pentenyl)cyclopentyl)- N- ethyl- 5- heptenamide
|
ChemIDplus
|
bimatoprost
|
WHO MedNet
|
155206-00-1
|
CAS Registry Number
|
ChemIDplus
|
|